Public health care will take a hit however Britain leaves the European Union, but a no-deal exit will cause the most harm, a new analysis shows.

From the effects of political upheaval on research to claims of gene-edited babies, the year has been a tumultuous one for the scientific community.

Watch as Nobel laureate Venki Ramakrishnan, who wrote the December Reading Frames essay, discusses Brexit and the importance of sharing scientific insights with the public.

Nearly three dozen Nobel laureates and Fields Medal winners sign a letter to the UK Prime Minister and the President of the European Commission.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.

The plan would also allow non-EU countries to pay to participate in EU research programs, albeit without wielding “decisional power.”

The budget is smaller than what some researchers hoped for, and too high for at least one EU member state.

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.